Latest filing published 01 Nov 2017 for Oramed Pharmaceuticals INC., €55k.
Insider track record
David Mark Slager: trading record in brief
David Mark Slager appears in our data through filings on Oramed Pharmaceuticals Inc. shares, published by SEC (Form 4). We count 2 filings; the first trade dates from 17 August 2017 and the latest from 31 October 2017.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 1 November 2017 came the latest disclosure, an option exercise for €55k in Oramed Pharmaceuticals Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to David Mark Slager
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 16,892 shares@ US$3.7713.1% of flowCommon StockSEC:0001213900-17-011195:0
- 112,613 shares@ US$3.7786.9% of flowCommon StockSEC:0001213900-17-008982:0
2 of 2 declarations
